Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.3 USD | +1.71% |
|
+23.96% | +105.85% |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+105.85% | 1.08B | |
+26.89% | 47.07B | |
+46.68% | 42.06B | |
-4.41% | 39.98B | |
+37.10% | 33.02B | |
-7.79% | 27.9B | |
+18.85% | 27.63B | |
+49.17% | 14.37B | |
+41.98% | 13.45B | |
-0.13% | 12.03B |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- Insider Sell: ARS Pharmaceuticals